Stockreport

Albireo Announces Research on Cholestatic Liver Diseases to be Presented at Major North American Liver Meetings

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF Study results to be presented at NASPGHAN demonstrate reductions in bile acids and bilirubin are highly associated with decreased aggregate need for liver transplant in [Read more]